Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | C-statistic (95% CI) | |
---|---|---|---|---|---|
No hepatotoxicity (n = 112) | |||||
Overall | 94% (86–98%) (66/70) | 83% (69–93%) (35/42) | 90% (81–96%) (66/73) | 90% (76–97%) (35/39) | 0.89 (0.82–0.95) |
ICD-9-CM | 94% (82–99%) (44/47) | 81% (61–93%) (21/26) | 90% (78–97%) (44/49) | 88% (68–97%) (21/24) | 0.87 (0.79–0.96) |
ICD-10 | 96% (78–100%) (22/23) | 88% (62–98%) (14/16) | 92% (73–99%) (22/24) | 93% (68–100%) (14/15) | 0.92 (0.82–1.00) |
Hepatotoxicity (n = 69) * | |||||
Overall | 86% (75–93%) (59/69) | N/A | 100% (NA) (59/59) | 0% (NA) (0/10) | N/A |
ICD-9-CM | 88% (74–96%) (37/42) | N/A | 100% (NA) (37/37) | 0% (NA) (0/5) | N/A |
ICD-10 | 81% (62–94%) (22/27) | N/A | 100% (NA) (22/22) | 0% (NA) (0/5) | N/A |